39 results
8-K
EX-99.2
ABOS
Acumen Pharmaceuticals Inc
14 May 24
Acumen Pharmaceuticals Reports First Quarter 2024 Financial Results and Business Highlights
7:35am
Disease Assessment Scale – Cognitive Subscale; ADCS-ADL: Alzheimer's Disease Cooperative Study – Activities of Daily Living 26
27© Copyright 2020
8-K
EX-99.1
sas2xf
19 Mar 24
Corporate Presentation March 2024 1
8:05am
8-K
EX-99.1
wkjq0
12 Jan 24
Corporate Presentation January 2024 1
8:42am
8-K
EX-99.1
qj6i1e
8 Jan 24
Regulation FD Disclosure
8:33am
8-K
EX-99.1
98kihec6v y0sr8vbk3
4 Dec 23
Corporate Presentation December 2023 1
7:45am
8-K
EX-99.1
a7kjh3f u6dj
13 Nov 23
Corporate Presentation November 2023 1
5:10pm
8-K
EX-99.2
d20zeb
8 Aug 23
Acumen Pharmaceuticals Reports Second Quarter 2023 Financial Results and Business Highlights
7:33am
424B5
m4fegb nnpzc
20 Jul 23
Prospectus supplement for primary offering
4:11pm
8-K
EX-1.1
xpr9x
20 Jul 23
Entry into a Material Definitive Agreement
4:06pm
424B5
8swvdoa1bx
17 Jul 23
Prospectus supplement for primary offering
4:49pm
8-K
u5rx30tugnmd
17 Jul 23
Acumen Pharmaceuticals Presents Positive Topline Results from First-in-Human
6:06am
8-K
EX-99.1
ywsvc9ecutunu20
17 Jul 23
Acumen Pharmaceuticals Presents Positive Topline Results from First-in-Human
6:06am
8-K
EX-99.2
60zops
17 Jul 23
Acumen Pharmaceuticals Presents Positive Topline Results from First-in-Human
6:06am
8-K
EX-99.2
8dqe ulh0b
9 May 23
Acumen Pharmaceuticals Reports First Quarter 2023 Financial Results and Business Highlights
7:08am